Transgenomic, Inc. (TBIO), (Nasdaq: TBIO) announced the launch of its new CLIA assays that detect the presence of the EGFR ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE